Diabetes and pancreatic cancer
INFORMATION & SUPPORT
Diabetes and pancreatic cancer are connected in both directions. Diabetes that has been present for many years is one of the risk factors for pancreatic cancer. Diabetes that is new, or that suddenly becomes much harder to control, can sometimes be an early sign of it. And once pancreatic cancer is being treated, blood sugar often becomes harder to manage. This guide keeps those three situations separate, because each one calls for something different.
One reassurance belongs at the top: most people who develop diabetes will never develop pancreatic cancer. New diabetes is common; pancreatic cancer is not. What matters is knowing which changes are worth having assessed, and how to manage blood sugar well during pancreatic cancer care in Canada.
Part of our Complications of pancreatic cancer guides. It is also linked from our Signs and symptoms and Risk factors guides.
On this page: How they are connected · When to have changes checked · Type 3c diabetes · During treatment · Eating · Low and high blood sugar · Questions to ask
How are diabetes and pancreatic cancer connected?
Long-standing diabetes. People who have lived with type 2 diabetes for many years develop pancreatic cancer somewhat more often than people without diabetes. Diabetes is one risk factor among several — it does not mean diabetes causes most pancreatic cancer, and most people with diabetes never develop it.
New or worsening diabetes. In some people, blood sugar begins to rise in the years before pancreatic cancer is found — studies of medical records show the rise can start up to about three years before diagnosis. Diabetes that appears for the first time later in life, or long-stable diabetes that suddenly becomes difficult to control, can occasionally be the cancer's first noticeable effect rather than a separate condition.
Diabetes during pancreatic cancer care. The pancreas makes insulin, so a tumour, surgery, and some treatments can all disturb blood-sugar control. Many people need closer monitoring, changed medicines, or insulin for the first time during treatment — this is a management task, not a personal failure.
When should diabetes changes be checked?
Ask for assessment — rather than watching and waiting — if diabetes is new and arrives together with unexplained weight loss, or if your blood sugar suddenly becomes much harder to control without a clear reason such as a new medicine or an illness. The combination of new diabetes and losing weight without trying is the pattern doctors take most seriously.
This is a reason to have things checked, not a reason to conclude you have cancer. The large majority of new diabetes has ordinary causes. Assessment usually starts with your family doctor or diabetes team, who can examine you, review your medicines and blood work, and decide whether imaging or referral is warranted. Our signs and symptoms guide covers the other symptoms that should be assessed promptly.
What is type 3c diabetes?
Type 3c diabetes — also called pancreatogenic diabetes — is diabetes caused by damage to the pancreas itself, rather than by the insulin resistance of type 2 diabetes. Pancreatic cancer is one of its causes; pancreatitis and pancreatic surgery are others.
It behaves differently because a damaged pancreas may produce too little insulin and too little glucagon (the hormone that raises blood sugar), alongside too few digestive enzymes. Blood sugar can swing more widely, and lows can be harder to head off. Management may involve tablets, insulin, closer monitoring, nutritional support, and pancreatic enzymes taken with food.
Not everyone with pancreatic cancer has type 3c diabetes, and the label matters mainly because it changes how your team manages your blood sugar. If nobody has named which type of diabetes you have, ask — the answer shapes the plan.
What changes during treatment?
Steroids. Steroid medicines given with chemotherapy, such as dexamethasone, commonly push blood sugar up for the days around treatment. The Saskatchewan Cancer Agency's patient guidance names steroids plainly as one of the treatments that change blood sugar during cancer care. Ask whether your readings need checking more often on steroid days, and whether your diabetes medicines should change for those days.
Eating less, nausea, and vomiting. Chemotherapy can cut appetite and cause vomiting, which pushes blood sugar down and can make regular diabetes medicines too strong for what you have actually eaten. Agree on a sick-day plan with your team before you need one: which medicines to take when you cannot eat, when to check more often, and when to call. Our nausea, vomiting and fatigue guide covers the symptom side of this.
Surgery. If part of the pancreas is removed, the remaining pancreas may make less insulin, and diabetes can start or worsen afterwards. If the whole pancreas is removed, the body makes no insulin at all and insulin treatment is lifelong. Either way, expect your diabetes plan to be reviewed after surgery — our surgery guide covers the operations themselves.
Enzymes and absorption. Pancreatic enzyme replacement helps you absorb food properly, and steadier absorption makes blood sugar steadier and easier to predict. If your glucose swings do not match what you ate, tell your team — enzyme timing is one of the things they can adjust. See our pancreatic enzymes (PERT) guide.
Eating without losing more weight
Standard type 2 diabetes advice often aims at weight loss. During pancreatic cancer care, that advice usually does not apply: keeping weight and strength up is part of treatment, and unintentional weight loss is itself a warning sign. Do not start a weight-loss diet, cut out carbohydrates, or follow "starve the cancer" advice — none of that treats pancreatic cancer, and it can leave you weaker.
The workable middle ground is regular meals and snacks built around protein and energy, with carbohydrate spread across the day rather than eliminated, adjusted with your own readings and medicines. A registered dietitian who understands both diabetes and pancreatic cancer is the right person to build that plan with you. Our nutrition guide and cachexia guide cover eating and weight loss in more depth.
Low and high blood sugar
Recognising a low. Low blood sugar (hypoglycemia) can cause shaking, sweating, a racing heart, hunger, blurred vision, irritability, or trouble concentrating. During cancer treatment it can happen when you have eaten less than usual, vomited, or taken your usual diabetes medicines on a day your intake dropped.
Treating a low. Treat a low promptly with fast-acting carbohydrate, following the steps and amounts in your own diabetes plan — Diabetes Canada's patient guidance sets out the standard sequence, including rechecking after treatment and following with a snack or meal when the next meal is not soon. If you have had lows during treatment, ask your team to review your medicines and your sick-day plan, and ask whether a glucagon prescription is appropriate for you.
High blood sugar. High blood sugar can cause thirst, passing urine more often, tiredness, and blurred vision, and it raises the risk of infection. Steroid days are the most common cause during chemotherapy. Readings that stay high, or high readings together with feeling unwell, are a reason to contact your team rather than simply waiting for the next cycle.
Ask your team for their daytime and after-hours numbers before you need them, and keep them with your medicines list. Do not wait for a website response about a medical concern.
Questions to ask your care team
- Which type of diabetes do I have — long-standing type 2, new-onset, or type 3c?
- Should this change in my blood sugar be investigated further?
- How will steroids affect my readings, and should my medicines change on those days?
- What are my personal blood-sugar targets during treatment?
- What is my sick-day plan if I cannot eat, or I am vomiting?
- After surgery, how will my insulin or tablets be reviewed?
- Who do I contact about blood sugar — my cancer team or my diabetes team — and whom do I call after hours?
Related guides
Sources
- Diabetes Canada — Hypoglycemia (low blood sugar) — recognition and the standard treatment sequence.
- Diabetes Canada — diabetes.ca — blood-sugar targets, sick-day planning, and diabetes education in Canada.
- Saskatchewan Cancer Agency — "Cancer Treatment and Blood Glucose" (patient handout, PDF) — steroids and treatment effects, warning signs, and when to get help.
- BC Cancer — "Glucagon Follow-Up Instructions" (patient handout, PDF) — care after a treated low, including follow-up eating and monitoring.
- National Institutes of Health, MedlinePlus Magazine — "New pancreatic cancer research may improve detection and treatment" — the new-onset diabetes research programme.
This guide is general information about diabetes for people with pancreatic cancer in Canada, not medical advice. Blood-sugar management is individual — discuss your targets, medicines, and sick-day plan with your care team.
Last reviewed: November 17, 2026 · This guide has not yet been medically reviewed. · Report an error